Hutchmed China gets NMPA approval for ATLED in ICC
Hutchmed China Ltd received NMPA approval for ATLED (fanregratinib) for ICC.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.